Polypharmacy and Geriatrics

This book aims to collate contemporary, evidence-based literature regarding the safe and quality use of medicines in older people. It considers the role of engaging consumers in all parts of clinical care and throughout all stages of research to create real-world impact. It includes practical clinical implications from the perspectives of healthcare professionals including physicians, nurses, and pharmacists to improve the use of medicines in older people and reduce their risk of medicine-related harm.

Summarises contemporary evidence-based literature to provide insights into optimising medicine use in older people Highlights the importance of involving consumers in research to enhance the relevance and impact of research findings Provides practical advice for clinicians and researchers to improve the quality of care for older people

Auteur

Dr Nagham Ailabouni is a clinician-researcher and NHMRC Emerging Leadership Fellow (EL1) at the University of Queensland, Faculty of Health and Behavioural Sciences. Dr Ailabouni has practiced clinically as a pharmacist in various healthcare settings. Dr Ailabouni's main research interests include implementation science, co-design and consumer engagement in person-centred deprescribing, quality use of medicines in older people, people living with dementia and their carers.

Contenu

Introduction.- Optimising medicine use.- Deprescribing in older people.- Development and implementation of deprescribing guidelines.- The power of the Consumer voice in Knowledge Translation of Deprescribing.- How to age well? Quality of life and polypharmacy in health services research and clinical practice.- Considering frailty in optimising medicine use.- Considering kidney and liver function when prescribing and reviewing medicines in older people.- Dementia and Mild Cognitive impairment.- Healthcare professional perspectives on managing medications in older people in different healthcare settings.